As of 2025-05-12, the EV/EBITDA ratio of Hofseth Biocare ASA (HBC.OL) is -12.87. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HBC.OL's latest enterprise value is 982.87 mil NOK. HBC.OL's TTM EBITDA according to its financial statements is -76.38 mil NOK. Dividing these 2 quantities gives us the above HBC.OL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.3x - 8.8x | 8.6x |
| Forward P/E multiples | 10.4x - 14.3x | 12.1x |
| Fair Price | (2.38) - (2.08) | (2.37) |
| Upside | -212.4% - -198.0% | -211.7% |
| Date | EV/EBITDA |
| 2025-05-09 | -12.87 |
| 2025-05-08 | -12.76 |
| 2025-05-07 | -12.40 |
| 2025-05-06 | -12.25 |
| 2025-05-05 | -11.68 |
| 2025-05-02 | -11.99 |
| 2025-04-30 | -11.99 |
| 2025-04-29 | -11.86 |
| 2025-04-28 | -11.68 |
| 2025-04-25 | -11.06 |
| 2025-04-24 | -11.01 |
| 2025-04-23 | -11.94 |
| 2025-04-22 | -12.09 |
| 2025-04-16 | -12.56 |
| 2025-04-15 | -12.76 |
| 2025-04-14 | -12.76 |
| 2025-04-11 | -12.76 |
| 2025-04-10 | -12.76 |
| 2025-04-09 | -12.30 |
| 2025-04-08 | -12.40 |
| 2025-04-07 | -12.25 |
| 2025-04-04 | -13.64 |
| 2025-04-03 | -14.06 |
| 2025-04-02 | -14.78 |
| 2025-04-01 | -14.63 |
| 2025-03-31 | -14.63 |
| 2025-03-28 | -14.73 |
| 2025-03-27 | -14.78 |
| 2025-03-26 | -14.63 |
| 2025-03-25 | -14.16 |
| 2025-03-24 | -14.21 |
| 2025-03-21 | -13.80 |
| 2025-03-20 | -14.01 |
| 2025-03-19 | -13.95 |
| 2025-03-18 | -13.80 |
| 2025-03-17 | -13.64 |
| 2025-03-14 | -13.28 |
| 2025-03-13 | -12.71 |
| 2025-03-12 | -12.71 |
| 2025-03-11 | -12.76 |
| 2025-03-10 | -13.75 |
| 2025-03-07 | -14.68 |
| 2025-03-06 | -14.57 |
| 2025-03-05 | -14.83 |
| 2025-03-04 | -14.32 |
| 2025-03-03 | -17.21 |
| 2025-02-28 | -17.26 |
| 2025-02-27 | -17.57 |
| 2025-02-26 | -17.63 |
| 2025-02-25 | -17.42 |